These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21436588)

  • 1. FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.
    Watkins SK; Zhu Z; Riboldi E; Shafer-Weaver KA; Stagliano KE; Sklavos MM; Ambs S; Yagita H; Hurwitz AA
    J Clin Invest; 2011 Apr; 121(4):1361-72. PubMed ID: 21436588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated dendritic cells: molecular mechanisms to suppress antitumor immunity.
    Hirohashi Y; Sato N
    Immunotherapy; 2011 Aug; 3(8):945-7. PubMed ID: 21843082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerogenic pDCs: spotlight on Foxo3.
    Bronte V
    J Clin Invest; 2011 Apr; 121(4):1247-50. PubMed ID: 21436582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous presence of FOXO3-specific T cells in cancer patients.
    Larsen SK; Ahmad SM; Idorn M; Met Ö; Martinenaite E; Svane IM; Straten PT; Andersen MH
    Oncoimmunology; 2014; 3(8):e953411. PubMed ID: 25960934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO3-NF-κB RelA Protein Complexes Reduce Proinflammatory Cell Signaling and Function.
    Thompson MG; Larson M; Vidrine A; Barrios K; Navarro F; Meyers K; Simms P; Prajapati K; Chitsike L; Hellman LM; Baker BM; Watkins SK
    J Immunol; 2015 Dec; 195(12):5637-47. PubMed ID: 26561547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.
    Wang ST; Chang CC; Yen MC; Tu CF; Chu CL; Peng YT; Chen DY; Lan JL; Lin CC
    Gene Ther; 2011 Apr; 18(4):372-83. PubMed ID: 21107437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
    Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
    Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
    Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
    Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.
    Degl'Innocenti E; Grioni M; Boni A; Camporeale A; Bertilaccio MT; Freschi M; Monno A; Arcelloni C; Greenberg NM; Bellone M
    Eur J Immunol; 2005 Jan; 35(1):66-75. PubMed ID: 15597325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective depletion of CD11c
    Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
    Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells.
    Xiao S; Zhu B; Jin H; Zhu C; Umetsu DT; DeKruyff RH; Kuchroo VK
    Eur J Immunol; 2011 Jun; 41(6):1539-49. PubMed ID: 21469101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.
    Shafer-Weaver KA; Watkins SK; Anderson MJ; Draper LJ; Malyguine A; Alvord WG; Greenberg NM; Hurwitz AA
    Cancer Res; 2009 Aug; 69(15):6256-64. PubMed ID: 19622771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells.
    Dejean AS; Beisner DR; Ch'en IL; Kerdiles YM; Babour A; Arden KC; Castrillon DH; DePinho RA; Hedrick SM
    Nat Immunol; 2009 May; 10(5):504-13. PubMed ID: 19363483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.
    Donkor MK; Sarkar A; Savage PA; Franklin RA; Johnson LK; Jungbluth AA; Allison JP; Li MO
    Immunity; 2011 Jul; 35(1):123-34. PubMed ID: 21757379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
    Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
    Front Immunol; 2020; 11():1820. PubMed ID: 33013832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
    Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors.
    Zheng X; Gao JX; Zhang H; Geiger TL; Liu Y; Zheng P
    J Immunol; 2002 Nov; 169(9):4761-9. PubMed ID: 12391185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF15 Regulates Malat-1 Circular RNA and Inactivates NFκB Signaling Leading to Immune Tolerogenic DCs for Preventing Alloimmune Rejection in Heart Transplantation.
    Zhang Y; Zhang G; Liu Y; Chen R; Zhao D; McAlister V; Mele T; Liu K; Zheng X
    Front Immunol; 2018; 9():2407. PubMed ID: 30425709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO3 as a new IKK-ε-controlled check-point of regulation of IFN-β expression.
    Luron L; Saliba D; Blazek K; Lanfrancotti A; Udalova IA
    Eur J Immunol; 2012 Apr; 42(4):1030-7. PubMed ID: 22531926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
    Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
    J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.